Ksenia Blinova,
Senior Technical Manager, Induced Pluripotent Stem Cell and Electrophysiology Core Facility
Dr. Blinova leads an Induced Pluripotent Stem Cell and Electrophysiology Core Facility at FDA. It was established to foster collaborative regulatory research supporting review and assessment of FDA-regulated products based on human induced-pluripotent stem cells, including lab-developed in vitro diagnostic tests, stem cell based combination products, high-throughput cardiotoxicity and neurotoxocity screening of new drugs, and patient-specific precision medicine. Dr. Blinova received her Ph.D. in physics and mathematics from Moscow State University and completed a postdoctoral fellowship at the National Heart, Lung, and Blood Institute and FDA Commissioner’s Fellowship Program at the FDA.
|
|
|
